DiaMedica Therapeutics Inc. (DMAC)
NASDAQ: DMAC · IEX Real-Time Price · USD
3.440
-0.050 (-1.43%)
At close: Jul 23, 2024, 3:59 PM
3.290
-0.150 (-4.36%)
After-hours: Jul 23, 2024, 4:25 PM EDT

DiaMedica Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 2016
Net Income
-19.27-19.3-13.7-13.64-12.3-10.65
Upgrade
Depreciation & Amortization
0.10.10.090.080.070.07
Upgrade
Share-Based Compensation
1.751.681.51.561.841.16
Upgrade
Other Operating Activities
-2.87-1.210.6-0.251.20.31
Upgrade
Operating Cash Flow
-20.29-18.73-11.51-12.25-9.19-9.1
Upgrade
Capital Expenditures
-0.03-0.02-0.08-0.02-0.030.01
Upgrade
Change in Investments
-16.57-18.2811.62-20.52-16.1-3.92
Upgrade
Investing Cash Flow
-16.6-18.311.54-20.54-16.13-3.91
Upgrade
Share Issuance / Repurchase
36.8536.85030.0928.850.08
Upgrade
Debt Issued / Paid
-0.01-0.01-0.01-0.01-0.01-0.01
Upgrade
Financing Cash Flow
36.8436.84-0.0130.0928.850.07
Upgrade
Net Cash Flow
-0.05-0.190.02-2.73.53-12.94
Upgrade
Free Cash Flow
-20.32-18.75-11.59-12.27-9.22-9.09
Upgrade
Free Cash Flow Per Share
-0.54-0.58-0.44-0.59-0.59-0.76
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).